# EDGAR Filing Document

**Accession Number:** 0001854445
**File Stem:** 0001493152-25-022290
**Filing Date:** 2025-11
**Character Count:** 83858
**Document Hash:** c3c08a450ebcac64b20ed37d42d9a31f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-022290.hdr.sgml**: 20251113

**ACCESSION NUMBER**: 0001493152-25-022290

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 63

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251113

**DATE AS OF CHANGE**: 20251113

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Glimpse Group, Inc.
- **CENTRAL INDEX KEY:** 0001854445
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER PROGRAMMING SERVICES [7371]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 812958271
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40556
- **FILM NUMBER:** 251478361

**BUSINESS ADDRESS:**
- **STREET 1:** 15 WEST 38TH ST, 12TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10018
- **BUSINESS PHONE:** 917-292-2685

**MAIL ADDRESS:**
- **STREET 1:** 15 WEST 38TH ST, 12TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10018

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 10-Q**

**(Mark One)**

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** 

**For the quarterly period ended September 30, 2025**

**OR**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from to** 

**Commission File Number: 001-40556**

**THE GLIMPSE GROUP, INC.**

**(Exact name of registrant as specified in its charter)**

---

| | |
|:---|:---|
| **Nevada** | **81-2958271** |
| **(State or other jurisdiction of**<br> **incorporation or organization)** | **(I.R.S. Employer**<br> **Identification No.)** |
| **15 West 38th St., 12th Floor**<br> **New York, NY** | **10018** |
| **(Address of principal executive offices)** | **(Zip Code)** |

---

**Registrant's telephone number, including area code: (917) 292-2685**

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol** | **Name of each exchange on which registered** |
| Common Stock, $0.001 par value per share | VRAR | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ <br> Non-accelerated filer ☒ Smaller reporting company ☒ <br> Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐ No ☒

As of November 11, 2025, the registrant had 21,076,506 shares of common stock, par value $0.001 per share, outstanding.

**THE GLIMPSE GROUP, INC.**

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
|  |  | **Page No.** |
| **PART I** | FINANCIAL INFORMATION |  |
| ITEM 1. | FINANCIAL STATEMENTS (Unaudited) |  |
|  | [Condensed Consolidated Balance Sheets](#a_002) | 3 |
|  | [Condensed Consolidated Statements of Operations](#a_003) | 4 |
|  | [Condensed Consolidated Statements of Stockholders' Equity](#a_004) | 5 |
|  | [Condensed Consolidated Statements of Cash Flows](#a_005) | 6 |
|  | [Notes to Condensed Consolidated Financial Statements](#a_006) | 7 |
| ITEM 2. | [MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS](#a_009) | 19 |
| ITEM 3. | [QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK](#a_010) | 25 |
| ITEM 4. | [CONTROLS AND PROCEDURES](#a_011) | 25 |
| **PART II** | [OTHER INFORMATION](#a_012) | 26 |
| ITEM 1. | [LEGAL PROCEEDINGS](#a_013) | 26 |
| ITEM 1A. | [RISK FACTORS](#a_014) | 26 |
| ITEM 2. | [UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS](#a_015) | 26 |
| ITEM 6. | [EXHIBITS](#a_016) | 27 |
| [SIGNATURES](#a_017) | [SIGNATURES](#a_017) | 28 |

---

**THE GLIMPSE GROUP, INC.**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

---

| | | |
|:---|:---|:---|
|  | **As of<br> September 30, 2025** | **As of<br> June 30, 2025** |
|  | **(Unaudited)** | **(Audited)** |
| **ASSETS** |  |  |
| Cash and cash equivalents | $5562397 | $6832725 |
| Accounts receivable | 657110 | 840551 |
| Deferred costs | 421417 | 48971 |
| Notes receivable | 132600 | 160600 |
| Prepaid expenses and other current assets | 559504 | 289810 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 7333028 | 8172657 |
| Equipment and leasehold improvements, net | 50559 | 54898 |
| Right-of-use assets, net | 88231 | 122094 |
| Intangible assets, net | 9067 | 60717 |
| Goodwill | 10857600 | 10857600 |
| Other assets | 11100 | 11100 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $18349585 | $19279066 |
| **LIABILITIES AND STOCKHOLDERS' EQUITY** |  |  |
| Accounts payable | $155295 | $228371 |
| Accrued liabilities | 377818 | 446896 |
| Deferred revenue | 69868 | 52576 |
| Lease liabilities, current portion | 93204 | 127046 |
| Contingent consideration for acquisition | 1500000 | 1483583 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 2196185 | 2338472 |
| Long term liabilities |  |  |
| &nbsp;&nbsp;&nbsp;Lease liabilities, net of current portion | 1903 | 4704 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 2198088 | 2343176 |
| Commitments and contingencies |  |  |
| Stockholders' Equity |  |  |
| &nbsp;&nbsp;&nbsp;Preferred Stock, par value $0.001 per share, 20 million shares <br> authorized; 0 shares issued and outstanding |  |  |
| &nbsp;&nbsp;&nbsp;Common Stock, par value $0.001 per share, 300 million shares <br> authorized; 21,066,006 and 21,055,506 issued and outstanding, <br> respectively | 21067 | 21056 |
| &nbsp;&nbsp;&nbsp;Additional paid-in capital | 82755663 | 82506758 |
| &nbsp;&nbsp;&nbsp;Accumulated deficit | (66625233) | (65591924) |
| Total stockholders' equity | 16151497 | 16935890 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and stockholders' equity | $18349585 | $19279066 |

---

*The accompanying notes are an integral part of these condensed consolidated financial statements.* 

**THE GLIMPSE GROUP, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
|  | **For the Three Months Ended** | **For the Three Months Ended** |
|  | **September 30,** | **September 30,** |
|  | **2025** | **2024** |
| Revenue |  |  |
| &nbsp;&nbsp;&nbsp;Software services | $1247933 | $2229257 |
| &nbsp;&nbsp;&nbsp;Software license/software as a service | 147784 | 209112 |
| &nbsp;&nbsp;&nbsp;Royalty income | 2936 | - |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenue | 1398653 | 2438369 |
| Cost of goods sold | 390881 | 515303 |
| Gross profit | 1007772 | 1923066 |
| Operating expenses: |  |  |
| &nbsp;&nbsp;&nbsp;Research and development expenses | 973400 | 1120522 |
| &nbsp;&nbsp;&nbsp;General and administrative expenses | 979234 | 939712 |
| &nbsp;&nbsp;&nbsp;Sales and marketing expenses | 324089 | 738875 |
| &nbsp;&nbsp;&nbsp;Amortization of acquisition intangible assets | 51648 | 125541 |
| &nbsp;&nbsp;&nbsp;Change in fair value of acquisition contingent consideration | 16417 | 33319 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 2344788 | 2957969 |
| Loss from operations before other income | (1337016) | (1034903) |
| Other income: |  |  |
| &nbsp;&nbsp;&nbsp;Gain on sale of business | 240000 |  |
| &nbsp;&nbsp;&nbsp;Interest income | 63707 | 20711 |
| Net loss | $(1033309) | $(1014192) |
| &nbsp;&nbsp;&nbsp;Basic and diluted net loss per share | $(0.05) | $(0.06) |
| &nbsp;&nbsp;&nbsp;Weighted-average common shares outstanding for basic and diluted net loss per share | 21064979 | 18164217 |

---

*The accompanying notes are an integral part of these condensed consolidated financial statements.* 

**THE GLIMPSE GROUP, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY**

**(Unaudited)**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Common Stock** | **Common Stock** | | | |
|  | **Shares** | **Amount** | **Additional<br> Paid-In**<br> **Capital** | **Accumulated**<br>**Deficit** |<br>**Total** |
| Balance as of July 1, 2025 | 21055506 | $21056 | $82506758 | $(65591924) | $16935890 |
| Common stock and stock option-based compensation expense | 10500 | 11 | 146671 |  | 146682 |
| Stock option-based board of directors expense |  |  | 102234 |  | 102234 |
| Net loss | - | - | - | (1033309) | (1033309) |
| Balance as of September 30, 2025 | 21066006 | $21067 | $82755663 | $(66625233) | $16151497 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Common Stock** | **Common Stock** | | | |
|  | **Shares** | **Amount** | **Additional**<br> **Paid-In**<br>**Capital** | **Accumulated**<br>**Deficit** |<br>**Total** |
| Balance as of July 1, 2024 | 18158217 | $18158 | $74559600 | $(63039273) | $11538485 |
| Common stock and stock option-based compensation expense | 8000 | 8 | 354259 |  | 354267 |
| Stock option-based board of directors expense |  |  | 12460 |  | 12460 |
| Net loss | - | - | - | (1014192) | (1014192) |
| Balance as of September 30, 2024 | 18166217 | $18166 | $74926319 | $(64053465) | $10891020 |

---

*The accompanying notes are an integral part of these condensed consolidated financial statements.* 

**THE GLIMPSE GROUP, INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(Unaudited)** 

---

| | | |
|:---|:---|:---|
|  | **For the Three Months Ended September 30,** | **For the Three Months Ended September 30,** |
|  | **2025** | **2024** |
| **Cash flows from operating activities:** |  |  |
| &nbsp;&nbsp;&nbsp;Net loss | $(1033309) | $(1014192) |
| &nbsp;&nbsp;&nbsp;Adjustments to reconcile net loss to net cash used in operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization and depreciation | 64070 | 155594 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock and stock option-based compensation for employees and board of directors | 248916 | 366727 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of business | (240000) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisition contingent consideration fair value adjustment | 16417 | 33319 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjustment to operating lease right-of-use assets and liabilities | (2776) | (78238) |
| &nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | 183441 | (148461) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred costs | (372446) | (149591) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | (69695) | (38907) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets |  | 54246 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | (73076) | 39698 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities | (29078) | (20310) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred revenue | 17292 | 375070 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in operating activities | (1290244) | (425045) |
| **Cash flow from investing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchase of equipment | (8084) | (9456) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash used in investing activities | (8084) | (9456) |
| **Cash flows provided by financing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notes receivable repayments | 28000 | - |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by financing activities | 28000 | - |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net change in cash and cash equivalents | (1270328) | (434501) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents, beginning of period | 6832725 | 1848295 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents, end of period | $5562397 | $1413794 |

---

*The accompanying notes are an integral part of these condensed consolidated financial statements.* 

THE GLIMPSE GROUP, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

**<u>NOTE 1. DESCRIPTION OF BUSINESS</u>**

The Glimpse Group, Inc. ("Glimpse", the "Company") is an Immersive technology company, providing Virtual Reality ("VR"), Augmented Reality("AR") and Spatial Computing software and services. Glimpse's operating entities are located in the United States. The Company was incorporated in the State of Nevada in June 2016.

Glimpse's unique business model builds scale and a robust ecosystem, while simultaneously providing investors an opportunity to invest directly into this emerging industry via a diversified platform.

The Company completed an initial public offering ("IPO") of its common stock on the Nasdaq Capital Market Exchange ("NASDAQ") on July 1, 2021, under the ticker VRAR.

**<u>NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</u>**

*Basis of presentation*

The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information and the rules and regulations of the SEC. In the opinion of management, the unaudited condensed consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and reflect all adjustments, which include only normal recurring adjustments, necessary to present fairly the financial position as of September 30, 2025, the results of operations and cash flows for the three months ended September 30, 2025 and 2024. The financial data and other information disclosed in these notes to the interim financial statements related to these periods are unaudited. The results for the three months ended September 30, 2025 are not necessarily indicative of the results to be expected for the entire year ending June 30, 2026 or for any subsequent periods. The consolidated balance sheet as of June 30, 2025 has been derived from the audited consolidated financial statements at that date. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to the Securities and Exchange Commission's rules and regulations. These unaudited condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and notes thereto for the year ended June 30, 2025.

**Principles of Consolidation**

The accompanying condensed consolidated financial statements include the balances of Glimpse and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

**Customer Concentration and Credit Risk**

Three customers accounted for approximately 79% (35%, 27% and 17%, respectively) of the Company's total gross revenues during the three months ended September 30, 2025. One of the same customers and another customer accounted for approximately 57% (29% and 28%, respectively) of the Company's total gross revenues during the three months ended September 30, 2024.

Two customers accounted for approximately 68% (47% and 21%, respectively) of the Company's accounts receivable as of September 30, 2025. One of the same customers accounted for approximately 46% of the Company's accounts receivable as of June 30, 2025. No other customer accounted for greater than 10% of accounts receivable as of June 30, 2025.

The Company maintains cash in accounts that, at times, may be in excess of the Federal Deposit Insurance Corporation limit. The Company has not experienced any losses on such accounts.

**Fair Value of Financial Instruments**

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy, which is based on three levels of inputs, the first two of which are considered observable and the last unobservable, that may be used to measure fair value, is as follows:

● Level 1 — quoted prices (unadjusted) in active markets for identical assets or liabilities;

● Level 2 — inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or

● Level 3 — unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The Company classifies its cash equivalents within Level 1 of the fair value hierarchy on the basis of valuations based on quoted prices for the specific securities in an active market.

The Company's contingent consideration is categorized as Level 3 within the fair value hierarchy. Contingent consideration is recorded within contingent consideration in the Company's condensed consolidated balance sheets as of September 30 and June 30, 2025. Contingent consideration has been recorded at its fair values using unobservable inputs that include assumptions regarding financial forecasts and discount rates. The development and determination of the unobservable inputs for Level 3 fair value measurements and fair value calculations are the responsibility of the Company's management.

The Company's other financial instruments consist primarily of accounts receivable, accounts payable and other liabilities, and are reported at approximate fair value due to the short-term nature of these instruments.

**Revenue Recognition**

Nature of Revenues

The Company reports its revenues in three categories:

● Software Services: VR, AR and Spatial Computing projects, solutions and consulting services.

● Software License and Software-as-a-Service ("SaaS"): VR, AR or Spatial Computing software that is sold either as a license or as a SaaS subscription.

● Royalty Income: royalty income earned pursuant to specific agreements.

The Company applies the following steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:

● identify the contract with a customer;

● identify the performance obligations in the contract;

● determine the transaction price;

● allocate the transaction price to performance obligations in the contract;

● recognize revenue as the performance obligation is satisfied;

● determine that collection is reasonably assured.

Revenue is recognized when the Company satisfies its performance obligation under the contract by transferring the promised product to its customer or service is performed and collection is reasonably assured. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer. A portion of the Company's contracts have a single performance obligation, as the promise to transfer products or services is not separately identifiable from other promises in the contract and, therefore, not distinct. Other contracts can include various services and products which are at times capable of being distinct, and therefore may be accounted for as separate performance obligations.

Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products or providing services. As such, revenue is recorded net of returns, allowances, customer discounts, and incentives. Sales taxes and other taxes are excluded from revenues.

For distinct performance obligations recognized at a point in time, any unrecognized portion of revenue and any corresponding unrecognized expenses are presented as deferred revenue and deferred costs, respectively, in the accompanying balance sheets. Deferred costs include cash payroll costs and may include payments to consultants and vendors.

For distinct performance obligations recognized over time, the Company records deferred costs (costs in excess of billings) when revenue is recognized prior to invoicing, or deferred revenue (billings in excess of costs) when revenue is recognized subsequent to invoicing.

The Company recognizes royalty income pursuant to agreements with divested entities representing a percentage of said entities collected revenue.

Significant Judgments

The Company's contracts with customers may include promises to transfer multiple products/services. Determining whether products/services are considered distinct performance obligations that should be accounted for separately versus together may require significant judgment. Further, judgment may be required to determine the standalone selling price for each distinct performance obligation.

Disaggregation of Revenue

The Company generated revenue for the three months ended September 30, 2025 and 2024 by delivering: (i) Software Services, consisting primarily of VR/AR/Spatial Computing software projects, solutions and consulting services, (ii) Software Licenses & SaaS, consisting primarily of VR, AR and Spatial Computing software licenses or SaaS, and (iii) royalty income. The Company currently generates its revenues primarily from customers in the United States.

Revenue for a significant portion of Software Services projects and solutions (projects whereby, the development of the project leads to an identifiable asset with an alternative use to the Company) is recognized at the point of time in which the customer obtains control of the project, customer accepts delivery and confirms completion of the project. The Company also generates Software Services revenues which are custom project solutions (projects whereby, the development of the custom project leads to an identifiable asset with no alternative use to the Company, and, in which, the Company also has an enforceable right to payment under the contract) and are therefore recognized based on the percentage of completion using an input model with a master budget. The budget is reviewed periodically and percentage of completion adjusted accordingly.

Revenue for Software Services consulting services and website maintenance is recognized when the Company performs the services, typically on a monthly retainer basis.

Revenue for Software Licenses is recognized at the point of time in which the Company delivers the software and customer accepts delivery. Software Licenses often include third party components that are a fully integrated part of the Software License stack and are therefore considered as one deliverable and performance obligation. If there are significant contractually stated ongoing service obligations to be performed during the term of the Software License or SaaS contract, then revenues are recognized ratably over the term of the contract.

Timing of Revenue

The timing of revenue recognition for the three months ended September 30, 2025 and 2024 was as follows:

SCHEDULE OF TIMING REVENUE RECOGNITION

---

| | | |
|:---|:---|:---|
|  | **For the Three Months Ended** | **For the Three Months Ended** |
|  | **September 30,** | **September 30,** |
|  | **2025** | **2024** |
| Products and services transferred at a point in time | $914387 | $2183830 |
| Products and services transferred/recognized over time | 484266 | 254539 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Revenue | $1398653 | $2438369 |

---

Remaining Performance Obligations

Timing of revenue recognition may differ from the timing of invoicing to customers. The Company generally records a unbilled receivable asset when revenue is recognized prior to invoicing, or deferred revenue when revenue is recognized subsequent to invoicing.

For certain Software Services project contracts the Company invoices customers after the project has been delivered and accepted by the customer. Software Service project contracts typically consist of designing and programming software for the customer. In most cases, there is only one distinct performance obligation, and revenue is recognized upon completion, delivery and customer acceptance. Contracts may include multiple distinct projects that can each be implemented and operated independently of subsequent projects in the contract. In such cases, the Company accounts for these projects as separate distinct performance obligations and recognizes revenue upon the completion of each project or obligation, its delivery and customer acceptance.

For contracts recognized over time, deferred revenue include billings invoiced for software projects for which the contract's performance obligations are not complete.

In Software Services project contract situations, the Company invoices customers for a substantial portion of the project upon entering into the contract due to their custom nature and revenue is recognized based upon percentage of completion. Revenue recognized subsequent to invoicing is recorded as deferred revenue (billings in excess of cost) and revenue recognized prior to invoicing is recorded as a deferred cost (cost in excess of billings).

For Software Services consulting or retainer contracts, the Company generally invoices customers monthly at the beginning of each month in advance for services to be performed in the following month. The sole performance obligation is satisfied when the services are performed. Software Services consulting or retainer contracts typically consist of ongoing support for a customer's software or specified business practices.

For Software License contracts, the Company generally invoices customers when the software has been delivered to and accepted by the customer, which is also when the performance obligation is satisfied. For SaaS contracts, the Company generally invoices customers in advance at the beginning of the service term.

For multi-period Software License contracts, the Company generally invoices customers annually at the beginning of each annual coverage period. Software License contracts consist of providing clients with software designed by the Company. For Software License contracts, there are generally no ongoing support obligations unless specified in the contract (becoming a Software Service).

Unfulfilled performance obligations represent amounts expected to be earned by the Company on executed contracts. As of September 30, 2025 and 2024, the Company had approximately $2.92 million and $5.56 million, respectively, in unfulfilled performance obligations.

**Other Significant Accounting Policies**

There have been no material changes to other significant accounting policies from those detailed in the audited consolidated financial statements and notes thereto for the fiscal year ended June 30, 2025.

**Recent Accounting Pronouncements Not Yet Adopted**

In December 2023, the FASB issued Accounting Standards Update ("ASU") 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which includes amendments that further enhance income tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. The amendments are effective for the Company's annual periods beginning July 1, 2025. The Company is currently evaluating the ASU to determine its impact on the Company's disclosures.

**<u>NOTE 3. SEGMENT AND RELATED INFORMATION</u>**

The Company has one reportable segment managed on a consolidated basis: Immersive technology software development and commercialization. The Company derives revenue primarily in the United States and manages all business activities on a consolidated basis. The services are deployed to customers in a similar manner.

The Company's chief operating decision maker ("CDOM") is the Chief Executive Officer who reviews financial information presented on a consolidated basis to allocate resources, evaluate performance and make overall operating decisions. The measure of segment profit or loss that is most consistent with the condensed consolidated financial statements is net cash used in operating activities. The accounting policies of our single reportable segment are the same as those for the condensed consolidated financial statements. The level of disaggregation and amounts of significant revenue and cash expenses that are regularly provided to the CDOM are the same as presented in the condensed consolidated statement of cash flows. Likewise, the measure of segment assets is reported on the condensed consolidated balance sheets as total assets.

**<u>NOTE 4. QREAL AND GLIMPSE TURKEY DIVESTITURE</u>**

As part of an announced strategic realignment around Spatial Core and divestiture of non-core assets, effective October 1, 2024, the Company divested the business of its wholly owned subsidiary company QReal, LLC ("QReal") and its related operating entity GLIMPSE GROUP YAZILIM VE ARGE TİCARET ANONİM ŞİRKET ("Glimpse Turkey") in a management buyout by the then General Manager of QReal.

The Company did not experience a material change to its revenue for the year ended June 30, 2025 and does not expect material changes to its expected revenues for year ended June 30 2026. The Company retains the revenues from QReal's largest customer in full, until such time that the Company has collected and retained $1.35 million net cash in the aggregate, after taking into account all related operating expenses and fees (the "Milestone"). After satisfaction of the Milestone, the Company will receive a monthly cash revenue share for a period of 18 months in relation to any revenues generated from this same customer.

The assets, as defined in the divestiture agreement, of Qreal/Glimpse Turkey, were sold in return for a $1.56 million senior secured convertible note (the "Note") from the purchasing ("New") entity and a 10% equity stake in New entity. Principal payback of the note is tied directly to revenue collected by New entity (separate from the Milestone). The note converts to New entity equity upon certain equity capital raising of New entity, as defined. The Company accounts for the investment in New entity at cost ($100) because the Company does not control or have significant influence over the investment. The Company has also fully reserved against the Note as collectability is considered uncertain.

Revenue from the divested business that is not being retained going forward was approximately $0.06 million for the three months ended September 30, 2024.

Pursuant to the original acquisition of QReal by the Company in 2016, upon sale of the entity the original sellers are due 8% ("economic interest") of the Milestone proceeds. As the achievement of the Milestone is uncertain, liability for these payments will be recorded as actual Milestone proceeds occur. The Company recorded an expense of approximately $0.01 million related to the economic interest in sales and marketing expense on the condensed consolidated statement of operations for the three months ended September 30, 2025.

As of September 30, 2025, the Company has received $0.51 million of the Milestone.

In connection with the QReal divestiture, the Company made two personal loans to the majority owner of New entity to assist in startup funding of New entity. These loans are personally guaranteed by said majority owner. The loans bear interest at a nominal rate, have monthly repayment requirements and are due in full by October 31, 2025 and April 30, 2026, respectively. The net outstanding balance on the loans is recorded as of September 30 and June 30, 2025 in the condensed consolidated balance sheets as notes receivable.

**<u>NOTE 5. SALE OF BUSINESS</u>**

In August 2025, the Company closed on an agreement to sell the assets, as defined in the agreement, of its Pose With the Pros business for an initial consideration of $0.25 million in cash and potential future revenue royalties. In connection therewith, the Company received a $0.05 million nonrefundable prepayment of the consideration in June 2025 which is recorded in accrued liabilities in the consolidated balance sheet as of June 30, 2025. The remaining $0.20 million consideration is recorded in prepaid expenses and other current assets in the condensed consolidated balance sheet as of September 2025. The $0.20 million remaining consideration was received in October 2025 (see Note 11).

In the three months ended September 30, 2025 the Company recognized a gain on this transaction of $0.24 million which is recorded as gain on sale of business in the condensed consolidated statement of operations.

Revenue from the divested business was approximately $0.01 million and $0.11 million, respectively, for the three months ended September 30, 2025 and 2024.

**<u>NOTE 6. FINANCIAL INSTRUMENTS</u>**

**Cash and Cash Equivalents**

The Company's money market funds are categorized as Level 1 within the fair value hierarchy. As of September 30 and June 30, 2025, the Company's cash and cash equivalents were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** |
|  | **Cost** | **Unrealized Gain (Loss)** | **Fair Value** | **Cash and Cash Equivalents** |
| Cash | $127478 | $- |  | $127478 |
| Level 1: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Money market funds | 5434919 | - | $5434919 | 5434919 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total cash and cash equivalents | $5562397 | $- | $5434919 | $5562397 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **As of June 30, 2025** | **As of June 30, 2025** | **As of June 30, 2025** | **As of June 30, 2025** |
|  | **Cost** | **Unrealized Gain (Loss)** | **Fair Value** | **Cash and Cash Equivalents** |
| Cash | $130288 | $- |  | $130288 |
| Level 1: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Money market funds | 6702437 | - | $6702437 | 6702437 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total cash and cash equivalents | $6832725 | $- | $6702437 | $6832725 |

---

**Contingent Consideration**

Contingent consideration was valued at the time of acquisition using unobservable inputs and included using a Monte Carlo simulation model, which model incorporated revenue volatility, internal rate of return, and a risk-free rate. The development and determination of the unobservable inputs for Level 3 fair value measurements and fair value calculations are the responsibility of the Company's management with the assistance, at times, of a third-party valuation specialist.

During the three months ended September 30, 2025 the Company finalized the contingent consideration related to the acquisition of Brightline Interactive, LLC ("BLI") which resulted in a final contingent consideration payout of $1.50 million. This was paid in cash in October 2025 (see Note 11).

The change in fair value of contingent consideration for BLI for the three months ended September 30, 2025 was a non-cash expense of approximately $0.02 million included as change in fair value of acquisition contingent consideration in the condensed consolidated statement of operations. This reflects the change in the time value of money related to the present value of anticipated payment.

As of June 30, 2025, the Company's contingent consideration liability balance was as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **As of June 30, 2025** | **As of June 30, 2025** | **As of June 30, 2025** | **As of June 30, 2025** | **As of June 30, 2025** |
|  | **Contingent Consideration at Purchase Date** | **Consideration Paid** | **Changes in Fair Value** | **Fair Value** | **Contingent Consideration** |
| Level 3: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Contingent consideration - BLI | 7324900 | (2997894) | (2843423) | 1483583 | 1483583 |
| &nbsp;&nbsp;&nbsp;Contingent consideration - XRT | - | (499288) | 499288 | - | - |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total contingent consideration | $7324900 | $(2997894) | $(2843423) | $1483583 | $1483583 |

---

Actual BLI revenue through June 30, 2025 resulted in additional gross consideration of $1.50 million over the remainder of the contingent consideration payout period ending on July 31, 2025, payable in cash. Actual BLI revenue through July 31, 2025 did not trigger additional consideration. Accordingly, contingent consideration remaining for the BLI acquisition as of June 30, 2025 is calculated at the present value of the remaining $1.50 million cash discounted at risk-free interest rates from the estimated payment date.

The change in fair value of contingent consideration for BLI for the three months ended September 30, 2024 was a non-cash expense of approximately $0.07 million included as change in fair value of acquisition contingent consideration in the condensed consolidated statement of operations. This reflects the change in the time value of money related to the present value of anticipated payments.

The change in fair value of contingent consideration for XR Terra, LLC ("XRT") for the three months ended September 30, 2024 was a non-cash gain of approximately $0.03 million included as change in fair value of acquisition contingent consideration in the condensed consolidated statement of operations. This reflects the reversal of the estimated final consideration payment related to the acquisition of XRT. The contingent consideration payout period ended September 2024.

**<u>NOTE 7. DEFERRED COSTS AND DEFERRED REVENUE</u>**

As of September 30 and June 30, 2025, deferred costs totaling $421,417 and $48,971, respectively, consists of costs deferred under contracts not completed and recognized at a point in time ($39,232 and $48,971, respectively), and costs in excess of billings under contracts not completed and recognized over time ($382,185 and $0, respectively). As of September 30 and June 30, 2025, deferred revenue, totaling $69,868 and $52,576, respectively, consists of revenue deferred under contracts not completed and recognized at a point in time.

The following table shows the net activity of deferred cost and deferred revenue for the three months ended September 30, 2025 and the year ended June 30, 2025:

SCHEDULE OF RECONCILIATION OF COST IN EXCESS OF BILLING FOR CONTRACT RECOGNIZED OVER TIME

---

| | | |
|:---|:---|:---|
|  | **As of and for the three months ended September 30, 2025** | **As of and for the year ended June 30, 2025** |
| Deferred costs - beginning of period | $48971 | $170781 |
| Deferred cost recognized as cost of goods sold during period | (7357) | (170781) |
| Costs in excess of billings | 375440 |  |
| Costs incurred and not yet recognized as cost of goods sold | 4363 | 48971 |
| Deferred cost - end of period | $421417 | $48971 |
| Deferred revenue - beginning of period | $52576 | $72788 |
| Deferred revenue recognized as revenue during period | (31326) | (72788) |
| Payments received and not yet recognized as revenue | 48618 | 52576 |
| Deferred revenue - end of period | $69868 | $52576 |

---

**<u>NOTE 8. EQUITY</u>**

**Common Stock Issued**

*Common stock issued to Employees as Compensation*

During the three months ended September 30, 2025, the Company issued 10,500 unrestricted shares of common stock to an employee as compensation and recorded share-based compensation expense of approximately $0.01 million in sales and marketing expenses in the condensed consolidated statement of operations.

During the three months ended September 30, 2024, the Company issued 8,000 unrestricted shares of common stock to an employee as compensation and recorded share-based compensation expense of approximately $0.01 million in sales and marketing expenses in the condensed consolidated statement of operations.

**Warrants**

In connection with the July 2021 IPO, the November 2021 Securities Purchase Agreement ("SPA") and the December 2024 SPA, the Company issued warrants, which are exercisable into Company common shares on a one-for-one basis, as detailed below. The warrants are not publicly traded.

The remaining outstanding warrants as of September 30, 2025 are:

---

| | | | |
|:---|:---|:---|:---|
|  | **Warrants Outstanding** | **Exercise Price** | **Expiration Date** |
| July 2021 IPO | 87500 | $7.00 | June 2026 |
| November 2021 SPA | 481000 | $1.75 | November 2026 |
| November 2021 SPA | 169000 | $1.75 | May 2027 |
| Total | 737500 |  |  |

---

**Employee Stock-Based Compensation**

*Stock Option issuance to Executives*

In February 2023, pursuant to the Equity Incentive Plan, the Company granted certain executive officers 2.20 million stock options as a long-term incentive. The options have an exercise price of $7.00 per share. 0.22 million of these options vest ratably over four years ("Initial Options"). The remainder ("Target Options") vest in fixed amounts based on achieving various revenue or common stock prices within seven years of grant date. Given the Company's current stock price and revenue, the Company views the achievement of the milestones that would trigger vesting of the Target Options as remote.

*Equity Incentive Plan*

The Company's 2016 Equity Incentive Plan (the "Plan"), as amended, has approximately 13.17 million common shares reserved for issuance. As of September 30, 2025, there were approximately 7.34 million shares available for issuance under the Plan. The shares available are after the granting of 1.98 million shares of executive Target Options.

The Company recognizes compensation expense relating to awards ratably over the requisite period, which is generally the vesting period.

Stock options have been recorded at their fair value. The Black-Scholes option-pricing model assumptions used to value the issuance of stock options under the Plan for the specific periods below are noted in the following table:

---

| | | |
|:---|:---|:---|
|  | **For the Three Months Ended <br> September 30,** | **For the Three Months Ended <br> September 30,** |
|  | **2025** | **2024** |
| Weighted average expected terms (in years) | 6.0 | 6.0 |
| Weighted average expected volatility | 129.6% | 99.5% |
| Weighted average risk-free interest rate | 4.0% | 4.4% |
| Expected dividend yield | 0.0% | 0.0% |

---

The grant date fair value for options granted during the three months ended September 30, 2025 and 2024 was approximately $0.17 million and $0.10 million, respectively.

The following is a summary of the Company's stock option activity for the three months ended September 30, 2025 and 2024, excluding the executive Target Options:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | | **Weighted Average** | **Weighted Average** | |
|  |<br><br>**Options** |<br>**Exercise**<br>**Price** | **Remaining**<br>**Contractual**<br>**Term (Yrs)** |<br>**Intrinsic**<br>**Value** |
| Outstanding at July 1, 2025 | 2766206 | $3.37 | 5.6 | $- |
| Options Granted | 125000 | 2.31 | 9.9 |  |
| Options Exercised |  |  | 0.0 |  |
| Options Forfeited / Cancelled | (72804) | 3.15 | 7.0 | - |
| Outstanding at September 30, 2025 | 2818402 | $3.33 | 5.5 | $35000 |
| Exercisable at September 30, 2025 | 1917257 | $3.55 | 4.5 | $13694 |

---

The above table excludes executive Target Options: 1,980,000 granted, $7.00 exercise price, 7.4 remaining term in years, no intrinsic value. Vesting of these is considered remote.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | | **Weighted Average** | **Weighted Average** | |
|  |<br><br>**Options** |<br>**Exercise**<br>**Price** | **Remaining**<br>**Contractual**<br>**Term (Yrs)** |<br>**Intrinsic**<br>**Value** |
| Outstanding at July 1, 2024 | 3643880 | $3.95 | 6.5 | $- |
| Options Granted | 147000 | 2.50 | 9.8 |  |
| Options Exercised |  |  | 0.0 |  |
| Options Forfeited / Cancelled | (276488) | 4.15 | 8.5 | - |
| Outstanding at September 30, 2024 | 3514392 | $3.88 | 6.2 | $- |
| Exercisable at September 30, 2024 | 1979073 | $4.03 | 4.9 | $- |

---

The above table excludes executive Target Options: 1,980,000 granted, $7.00 exercise price, 8.4 remaining term in years, no intrinsic value. Vesting of these is considered remote.

The intrinsic value of stock options activity for the three months ended September 30, 2025 and 2024 was computed using a fair market value (fiscal year to date VWAP – volume weighted average price) of the common stock of $1.52 per share and $0.84 per share, respectively.

The intrinsic value of stock options outstanding and exercisable as of September 30, 2025 and 2024 was computed using NASDAQ market closing prices of the common stock of $1.64 per share and $0.76 per share, respectively.

The Company's stock option-based expense for the three months ended September 30, 2025 and 2024 consisted of the following:

---

| | | |
|:---|:---|:---|
|  | **For the Three Months Ended** | **For the Three Months Ended** |
|  | **September 30** | **September 30** |
|  | **2025** | **2024** |
| <u>Stock option-based expense:</u> |  |  |
| Research and development expenses | $35112 | $139190 |
| General and administrative expenses | 84683 | 113008 |
| Sales and marketing expenses | 13340 | 94068 |
| Board option expense | 102235 | 12460 |
| Total | $235370 | $358726 |

---

There is no expense included for the executive officers' Target Options.

As of September 30, 2025 total unrecognized compensation expense to employees, board members and vendors related to stock options was approximately $1.0 million (excluding executive Target Options of $8.08 million, which vesting and expense is considered remote) and is expected to be recognized over a weighted average period of 1.58 years (which excludes the executive Target Options).

**<u>NOTE 9. EARNINGS PER SHARE</u>**

The following table presents the computation of basic and diluted net loss per common share:

---

| | | |
|:---|:---|:---|
|  | **For the Three Months Ended** | **For the Three Months Ended** |
|  | **September 30,** | **September 30,** |
| Numerator: | **2025** | **2024** |
| &nbsp;&nbsp;&nbsp;Net loss | $(1033309) | $(1014192) |
| Denominator: |  |  |
| &nbsp;&nbsp;&nbsp;Weighted-average common shares outstanding <br> for basic and diluted net loss per share | 21064979 | 18164217 |
| Basic and diluted net loss per share | $(0.05) | $(0.06) |

---

Potentially dilutive securities, on a weighted average basis, that were not included in the calculation of diluted net loss per share attributable to common stockholders because their effect would be anti-dilutive are as follows (in common equivalent shares):

---

| | | |
|:---|:---|:---|
|  | **For the Three Months Ended** | **For the Three Months Ended** |
|  | **September 30,** | **September 30,** |
|  | **2025** | **2024** |
| Options | 4874710 | 5994282 |
| Warrants | 737500 | 837500 |
| &nbsp;&nbsp;&nbsp;Total | 5612210 | 6831782 |

---

Stock options above include 1,980,000 executive Target Options as of September 30, 2025 and 2024, respectively. Vesting of these is considered remote.

**<u>NOTE 10. COMMITMENTS AND CONTINGENCIES</u>**

**Lease Costs**

The Company made cash payments for all operating leases for the three months ended September 30, 2025 and 2024, of approximately $0.07 million and $0.19 million, respectively, which were included in net cash used in operating activities within the condensed consolidated statements of cash flows. As of September 30, 2025, the Company's operating leases have a weighted average remaining lease term of 0.48 years and weighted average discount rate of 8.33%.

The total rent expense for all operating leases for the three months ended September 30, 2025 and 2024, was approximately $0.06 million and $0.11 million, respectively.

**Lease Commitments**

The Company has various operating leases for its offices. These existing leases have remaining lease terms ranging from approximately 0.25 to 1.17 years. Certain lease agreements contain options to renew, with renewal terms that generally extend the lease terms by 1 to 3 years for each option. The Company determined that none of its current leases are expected to be renewed except one. That remaining lease will not be renewed under its current terms and will be renegotiated. Therefore, said lease does not have a measurable term or rate to calculate future lease payments beyond its current term.

Future approximate undiscounted lease payments for the Company's operating lease liabilities and a reconciliation of these payments to its operating lease liabilities as of September 30, 2025 are as follows:

---

| | |
|:---|:---|
| **Years Ended June 30,** | |
| 2026 | 118846 |
| 2027 | 4775 |
| Total future minimum lease commitments, including short-term leases | 123621 |
| Less: future minimum lease payments of short - term leases | (26250) |
| Less: imputed interest | (2264) |
| Present value of future minimum lease payments, excluding short term leases | $95107 |
| Current portion of operating lease liabilities | $93204 |
| Non-current portion of operating lease liabilities | 1903 |
| Total operating lease liability | $95107 |

---

**Contingent Consideration for Acquisitions**

Contingent consideration for acquisition consists of the following as of September 30 and June 30, 2025, respectively (see Notes 6 and 11):

---

| | | |
|:---|:---|:---|
|  | **As of September 30,** | **As of June 30,** |
|  | **2025** | **2025** |
| BLI | $1500000 | $1483583 |
| &nbsp;&nbsp;&nbsp;Total contingent consideration for acquisition | $1500000 | $1483583 |

---

**<u>NOTE 11. SUBSEQUENT EVENTS</u>**

In October 2025, the Company paid the sellers of BLI the final acquisition contingent consideration payment of $1.50 million in cash (see Notes 6 and 10).

In October 2025, the Company received $0.20 million in cash representing remaining consideration for sale of the Pose With The Pros business (see Note 5).

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations**

*The following discussion and analysis summarizes the significant factors affecting the consolidated operating results, financial condition, liquidity and cash flows of our Company as of and for the periods presented below. The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and related notes included in this Quarterly Report on Form 10-Q and our audited financial statements and notes thereto, and related disclosures, as of and for the fiscal year ended June 30, 2025, which are included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025 filed with the Securities and Exchange Commission (the "SEC"). Unless the context requires otherwise, references in this Quarterly Report on Form 10-Q to "we," "us," "our" or "the Company," refer to The Glimpse Group, Inc., a Nevada corporation.*

**Cautionary Statement Regarding Forward-Looking Statements**

**Overview**

We are an Immersive technology company, providing enterprise focused Virtual Reality (VR), Augmented Reality (AR) and Spatial Computing software and services (Immersive technologies). Glimpse's operating entities are located primarily in the United States. We believe that we offer significant exposure to the rapidly growing and potentially transformative Immersive technology markets, while mitigating downside risk via our diversified model and ecosystem.

Our ecosystem of Immersive technology entities, collaborative environment and diversified business model aims to simplify the challenges faced by companies in the emerging Immersive technology industry, create scale, build operational efficiencies, reduce time to market and enhance go-to-market synergies, while simultaneously providing investors an opportunity to invest directly via a diversified infrastructure.

The Immersive technology industry is an early-stage technology industry with nascent markets. We believe that this industry has significant growth potential across verticals, may be transformative, and that our diversified ecosystem creates important competitive advantages. We currently target a wide array of industry verticals, including but not limited to: Corporate Training, Education, Healthcare, Government & Defense, Branding/Marketing/Advertising, Retail, Media & Entertainment, Corporate Events and Social VR support groups and therapy. We focus primarily on the business-to-business (B2B) and business-to-business-to-consumer (B2B2C) segments, and we are hardware agnostic.

In fiscal year 2024, we shifted our businesses ("Strategic Shift") to focus on providing immersive technology solutions software and services that are primarily driven by Spatial Computing, Cloud and Artificial Intelligence (AI), including our product "Spatial Core," led by our entity Brightline Interactive, LLC ("BLI"). We believe that Spatial Core is a key differentiator, growth driver and competitive advantage for us.

At the time of this filing, we have approximately 40 full time employees, primarily software developers, engineers and 3D artists.

The Glimpse Group, Inc. was incorporated in June 2016 under the laws of the State of Nevada, and is headquartered in New York, New York.

Business Organization Chart (as of September 30, 2025):

![](form10-q_001.jpg)

**Significant Items**

***At-The-Market Offering***

On July 11, 2025, we entered into a Sales Agreement with WestPark Capital, Inc., as sales agent, pursuant to which we may offer and sell, from time to time through WestPark Capital, Inc., up to $3,081,340 of our common stock, by any method permitted by law and deemed to be an "at the market offering" as defined in Rule 415(a)(4) under the Securities Act. We refer to the foregoing transaction in this Quarterly Report on Form 10-Q as the "ATM Facility." No shares under the ATM Facility have been sold to date.

***SpatialCore Contract***

On August 13, 2025 we entered into a $2+ million SpatialCore contract to be delivered over a 12 month period.

***Potential Subsidiary Spin Off***

In September 2025, the Company's board of directors approved the exploration of a potential spin off of the Company's BLI subsidiary as a separate public company to potentially unlock shareholder value and provide growth resources to BLI. This process is in its early stages and its structure and success are uncertain and may not occur.

**Financial Highlights for the three months ended September 30, 2025 compared to the three months ended September 30, 2024.**

**Results of Operations**

The following table sets forth our results of operations for the three months ended September 30, 2025 and 2024:

***Summary P&L***

---

| | | | |
|:---|:---|:---|:---|
|  | **For the Three Months Ended** | **For the Three Months Ended** | |
|  | **September 30,** | **September 30,****Change** | **Change** |
|  | **2025** | **2024** | **%** |
|  | **(in millions)** | **(in millions)** | |
| Revenue | $1.40 | $2.44) | -43% |
| Cost of Goods Sold | 0.39 | 0.52) | -25% |
| &nbsp;&nbsp;&nbsp;Gross Profit | 1.01 | 1.92) | -47% |
| Total Operating Expenses | 2.34 | 2.96) | -21% |
| &nbsp;&nbsp;&nbsp;Loss from Operations before Other Income | (1.33) | (1.04) | -28% |
| Other Income | 0.30 | 0.02 | NA |
| &nbsp;&nbsp;&nbsp;Net Loss | $(1.03) | $(1.02) | -1% |

---

***Revenue***

 ****

---

| | | | |
|:---|:---|:---|:---|
|  | **For the Three Months Ended** | **For the Three Months Ended** | |
|  | **September 30,** | **September 30,****Change** | **Change** |
|  | **2025** | **2024** | **%** |
|  | **(in millions)** | **(in millions)** | |
| Software Services | $1.25 | $2.23) | -44% |
| Software License/Software as a Service | 0.15 | 0.21) | -29% |
| &nbsp;&nbsp;&nbsp;Total Revenue | $1.40 | $2.44) | -43% |

---

Total revenue for the three months ended September 30, 2025 was approximately $1.40 million compared to approximately $2.44 million for the three months ended September 30, 2024, decrease of approximately 43%. The decrease reflects timing of Department of War ("DoW") contracts and U.S. Government budget delays and run off of certain legacy VR/AR customers reflecting our Strategic Shift.

We break out our revenues into three categories - Software Services, Software License and Royalty Income.

● Software Services revenues are primarily comprised of Immersive technology projects, services related to our software licenses and consulting retainers.

● Software License revenues are comprised of the sale of our internally developed Immersive technology software as licenses or as software-as-a-service (SaaS).

● Royalty Income represents a percentage of revenue from divested subsidiaries pursuant to the respective divesture agreements.

For the three months ended September 30, 2025, Software Services revenue was approximately $1.25 million compared to approximately $2.23 million for the three months ended September 30, 2024, a decrease of approximately 44%. The decrease reflects timing of DoW contracts and U.S. Government budget delays and run off of certain legacy VR/AR customers reflecting our Strategic Shift.

For the three months ended September 30, 2025, Software License revenue was approximately $0.15 million compared to approximately $0.21 million for the three months ended September 30, 2024. The decrease was due to the license timing with a higher education customer.

Royalty income was negligible for the three months ended September 30, 2025 and zero for the prior year period.

***Customer Concentration***

Three customers accounted for approximately 79% (35%, 27% and 17%, respectively) of the Company's total gross revenues during the three months ended September 30, 2025. One of the same customers and a different customer accounted for approximately 57% (29% and 28%, respectively) of the Company's total gross revenues during the three months ended September 30, 2024.

***Gross Profit***

---

| | | | |
|:---|:---|:---|:---|
|  | **For the Three Months Ended** | **For the Three Months Ended** | |
|  | **September 30,** | **September 30,****Change** | **Change** |
|  | **2025** | **2024** | **%** |
|  | **(in millions)** | **(in millions)** | |
| Revenue | $1.40 | $2.44) | -43% |
| Cost of Goods Sold | 0.39 | 0.52) | -25% |
| &nbsp;&nbsp;&nbsp;Gross Profit | 1.01 | 1.92) | -47% |
| &nbsp;&nbsp;&nbsp;Gross Profit Margin | 72% | 79% |  |

---

Gross profit was approximately 72% for the three months ended September 30, 2025 compared to approximately 79% for the three months ended September 30, 2024. The decrease was primarily driven by the change in cost structure of DoW projects.

***Operating Expenses***

---

| | | | |
|:---|:---|:---|:---|
|  | **For theThree Months Ended** | **For theThree Months Ended** | |
|  | **September 30,** | **September 30,****Change** | **Change** |
|  | **2025** | **2024** | **%** |
|  | **(in millions)** | **(in millions)** | |
| Research and development expenses | $0.97 | $1.12) | -13% |
| General and administrative expenses | 0.98 | 0.94 | 4% |
| Sales and marketing expenses | 0.32 | 0.74) | -57% |
| Amortization of acquisition intangible assets | 0.05 | 0.13) | -62% |
| Change in fair value of acquisition contingent consideration | 0.02 | 0.03) | -33% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Operating Expenses | $2.34 | $2.96) | -21% |

---

Operating expenses for the three months ended September 30, 2025 were approximately $2.34 million compared to approximately $2.96 million for the three months ended September 30, 2024, a decrease of approximately 21%. The decrease reflects the divestiture of the QReal business and reduction in non-core businesses.

Research and Development

Research and development expenses for the three months ended September 30, 2025 were approximately $0.97 million compared to approximately $1.12 million for the three months ended September 30, 2024, a decrease of approximately 13%. The decrease was driven by the divestiture of the QReal business and reduction in non-core businesses.

General and Administrative

General and administrative expenses for the three months ended September 30, 2025 were approximately $0.98 million compared to approximately $0.94 million for the three months ended September 30, 2024, an increase of approximately 4%. The increase reflects increased investor relation efforts.

Sales and Marketing

Sales and marketing expenses for the three months ended September 30, 2025 were approximately $0.32 million compared to approximately $0.74 million for the three months ended September 30, 2024, a decrease of approximately 57%. This decrease represents the divestiture of the QReal business, reduction in non-core businesses and decrease in revenue driven incentive compensation.

Amortization of Acquisition Intangible Assets

Amortization of acquisition intangible assets expense for the three months ended September 30, 2025 was approximately $0.05 million compared to approximately $0.13 million for the three months ended September 30, 2024, a decrease of approximately 62%. The decrease is attributable to the run off of the remaining attributable useful life of the intangible acquisition assets.

Change in Fair Value of Acquisition Contingent Consideration

Change in fair value of acquisition contingent consideration expense for the three months ended September 30, 2025 was approximately $0.02 million compared to approximately $0.03 million for the three months ended September 30, 2024. The expense represents the change in the present value of BLI cash contingent consideration between balance sheet measurement dates.

***Other Income***

Other income for the three months ended September 30, 2025 was approximately $0.30 million compared to approximately $0.02 million for the three months ended September 30, 2024. 2025 primarily represents a gain on sale of the Pose With the Pros business. 2025 also reflects increased investable cash balances and associated interest income as a result of the equity raise in December 2024.

***Net Loss***

Net loss for the three months ended September 30, 2025 was approximately $1.03 million compared to approximately $1.02 million for the three months ended September 30, 2024. This reflects a reduction in 2025 revenue and gross margin, fully offset by a reduction in operating expenses and a gain on sale of the Pose With the Pros business.

**Non-GAAP Financial Measures**

The following discussion and analysis includes both financial measures in accordance with Generally Accepted Accounting Principles ("GAAP"), as well as non-GAAP financial measures. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flows that either excludes or includes amounts that are not normally included or excluded in the most directly comparable measure calculated and presented in accordance with GAAP. Non-GAAP financial measures should be viewed as supplemental to, and should not be considered as alternatives to, net income (loss), operating income (loss), and cash flow from operating activities, liquidity or any other financial measures. They may not be indicative of the historical operating results of the Company nor are they intended to be predictive of potential future results. Investors should not consider non-GAAP financial measures in isolation or as substitutes for performance measures calculated in accordance with GAAP. Our management uses and relies on EBITDA and Adjusted EBITDA, which are non-GAAP financial measures. We believe that both management and stockholders benefit from referring to the aforementioned non-GAAP financial measures in planning, forecasting and analyzing future periods.

Our management uses these non-GAAP financial measures in evaluating its financial and operational decision making and as a means to evaluate period-to-period comparisons. Our management recognizes that the non-GAAP financial measures have inherent limitations because of the described excluded items.

The Company defines Adjusted EBITDA as income (or loss) from continuing operations before the items in the table below. Adjusted EBITDA is an important measure of our operating performance because it allows management, investors and analysts to evaluate and assess our core operating results from period-to-period after removing the impact of items of a non-operational nature that affect comparability.

We have included a reconciliation of our financial measures calculated in accordance with GAAP to the most comparable non-GAAP financial measures. We believe that providing the non-GAAP financial measures, together with the reconciliation to GAAP, helps investors make comparisons between the Company and other companies. In making any comparisons to other companies, investors need to be aware that companies use different non-GAAP measures to evaluate their financial performance. Investors should pay close attention to the specific definition being used and to the reconciliation between such measures and the corresponding GAAP measures provided by each company under applicable SEC rules.

The following table presents a reconciliation of net loss to Adjusted EBITDA for the three months ended September 30, 2025 and 2024:

---

| | | |
|:---|:---|:---|
|  | **For the Three Months Ended** | **For the Three Months Ended** |
|  | **September 30,** | **September 30,** |
|  | **2025** | **2024** |
|  | **(in millions)** | **(in millions)** |
| Net loss | $(1.03) | $(1.02) |
| Depreciation and amortization | 0.06 | 0.16 |
| &nbsp;&nbsp;&nbsp;**EBITDA loss** | (0.97) | (0.86) |
| Stock based compensation expenses | 0.25 | 0.37 |
| Change in fair value of acquisition contingent consideration | 0.02 | 0.03 |
| Gain on sale of business | (0.24) | - |
| &nbsp;&nbsp;&nbsp;**Adjusted EBITDA loss** | $(0.92) | $(0.46) |

---

Adjusted EBITDA loss was $0.92 million for the three months ended September 30, 2025 compared to approximately $0.46 million loss for the three months ended September 30, 2024. This reflects a reduction in 2025 revenue and gross margin partially offset by a reduction in operating expenses.

**Liquidity and Capital Resources**

---

| | | | |
|:---|:---|:---|:---|
|  | **For the Three Months Ended** | **For the Three Months Ended** | |
|  | **September 30,** | **September 30,****Change** | **Change** |
|  | **2025** | **2024** | **%** |
|  | **(in millions)** | **(in millions)** | |
| Net cash used in operating activities | $(1.29) | $(0.42) | -207% |
| Net cash used in investing activities | (0.01) | (0.01) | NA |
| Net cash provided by financing activities | 0.03 | - | 100% |
| Net decrease in cash and cash equivalents | (1.27) | (0.43) | -195% |
| Cash and cash equivalents, beginning of period | 6.83 | 1.84 | 271% |
| Cash and cash equivalents, end of period | $5.56 | $1.41 | 294% |

---

***Operating Activities***

Net cash used in operating activities was approximately $1.29 million for the three months ended September 30, 2025, compared to approximately $0.42 million during the three months ended September 30, 2024. This reflects a reduction in 2025 revenue and gross margin which is partially offset by a reduction in operating expenses, and the timing of cash receipts on DoW projects.

***Investing Activities***

Net cash used in investing activities was flat year over year. The amount represents equipment purchases.

***Financing Activities***

Net cash provided by financing activities was approximately $0.03 million for the three months ended September 30, 2025, compared to zero for the prior year period. The 2025 amounts represent repayment of notes receivable related to the divestiture of QReal.

***Capital Resources***

As of September 30, 2025, the Company had cash and cash equivalents of $5.56 million, plus $0.66 million of accounts receivable.

As of September 30, 2025, the Company had no outstanding debt obligations.

As of September 30, 2025, the Company had no issued and outstanding preferred stock.

As of September 30, 2025, contingent consideration for acquisition liabilities represents a $1.50 million cash component which was paid in October 2025. This was the final payment due related to the BLI acquisition.

**Recently Adopted Accounting Pronouncements**

Please see Note 2 to the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q that describes the impact, if any, from the adoption of recent accounting pronouncements.

**Item 3. Quantitative and Qualitative Disclosures about Market Risk**

Not required for smaller reporting companies.

**Item 4. Controls and Procedures**

***Evaluation of Disclosure Controls and Procedures***

We maintain "disclosure controls and procedures," as such term is defined in Rule 13a-15(e) under the Exchange Act, that are designed to provide reasonable assurance that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of the end of such period.

In designing and evaluating our disclosure controls and procedures, management recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Additionally, in designing disclosure controls and procedures, we are required to apply judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures. The design of any disclosure controls and procedures also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

***Internal Control Over Financial Reporting***

During the period ended September 30, 2025, there was no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

**PART II - OTHER INFORMATION**

**Item 1. Legal Proceedings**

None.

**Item 1A. Risk Factors**

Our Annual Report on Form 10-K for the fiscal year ended June 30, 2025 contains a discussion of the material risks associated with our business. There have been no material changes to the risks described in such Annual Report on Form 10-K.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds**

***Recent Sale of Unregistered Equity Securities***

During the three months ended September 30, 2025, the Company issued 10,500 shares of common stock for:

---

| | | | |
|:---|:---|:---|:---|
|  | Number of Shares | Cash Proceeds | Value of Shares |
| Compensation and vendor expense | 10500 | - | 13545 |
| &nbsp;&nbsp;&nbsp;Total | 10500 | $- | $13545 |

---

Please refer to Note 8 of the unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q.

The foregoing transactions were exempt from the registration requirements of the Securities Act pursuant to Section 4(a)(2) thereof.

***Purchases of Equity Securities by the Issuer and Affiliated Purchasers***

None.

**Item 3. Defaults Upon Senior Securities**

Not Applicable.

**Item 4. Mine Safety Disclosures**

Not Applicable.

**Item 5. Other Information**

None.

**Item 6. Exhibits**

The following exhibits are filed as part of this Quarterly Report on Form 10-Q.

---

| | |
|:---|:---|
| **Exhibit**<br> **Number** | **Description of Exhibit** |
| 31.1 | [Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Exchange Act.](ex31-1.htm) |
| 31.2 | [Certification of Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Exchange Act.](ex31-2.htm) |
| 32.1 | [Certification of Principal Executive Officer and Principal Financial Officer pursuant to Rules 13a-14(b) or 15d-14(b) under the Exchange Act.](ex32-1.htm) |
| 101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document. |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized, on this 13<sup>th</sup> day of November, 2025.

---

| |
|:---|
| **THE GLIMPSE GROUP, INC.** |
| */s/ Lyron Bentovim* |
| Lyron Bentovim |
| Chief Executive Officer |
| (Principal Executive Officer) |
| */s/ Maydan Rothblum* |
| Maydan Rothblum |
| Chief Financial Officer |
| (Principal Financial Officer) |

---

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER**

I, Lyron Bentovim, Chief Executive Officer of The Glimpse Group, Inc., certify that:

1. I
 have reviewed this Quarterly Report on Form 10-Q of The Glimpse Group, Inc.;

2. Based
 on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
 to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to
 the period covered by this report;

3. Based
 on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
 respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in
 this report;

4. The
 registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
 (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange
 Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed
 such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
 to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
 within those entities, particularly during the period in which this report is being prepared.

(b) Designed
 such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
 supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
 for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated
 the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about
 the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
 and

(d) Disclosed
 in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's
 most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected,
 or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The
 registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
 reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing
 the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All
 significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
 reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information;
 and

(b) Any
 fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's
 internal control over financial reporting.

---

| | |
|:---|:---|
| Date: November 13, 2025 | */s/ Lyron Bentovim* |
|  | Lyron Bentovim |
|  | Chief Executive Officer |
|  | (Principal Executive Officer) |

---

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER**

I, Maydan Rothblum, Chief Financial Officer of The Glimpse Group, Inc., certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of The Glimpse Group, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared.

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: November 13, 2025 | */s/ Maydan Rothblum* |
|  | Maydan Rothblum |
|  | Chief Financial Officer |
|  | (Principal Financial Officer) |

---

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of The Glimpse Group, Inc. (the "Company") on Form 10-Q for the quarter ending September 30, 2025, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, in the capacities and on the date indicated below, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the knowledge of each of the undersigned:

&nbsp;&nbsp;&nbsp;&nbsp;1. The
 Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2. The
 information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
 of the Company.

Date: November 13, 2025

---

| |
|:---|
| */s/ Lyron Bentovim* |
| Lyron Bentovim |
| Chief Executive Officer |
| (Principal Executive Officer) |

---

---

| |
|:---|
| */s/ Maydan Rothblum* |
| Maydan Rothblum |
| Chief Financial Officer |
| (Principal Financial Officer) |

---